DIA423.85+7.52 1.81%
SPX5,921.54+118.72 2.05%
IXIC19,199.16+461.96 2.47%

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga·01/12/2023 17:31:03
Listen to the news

Gainers

  • Yield10 Bioscience (NASDAQ:YTEN) shares increased by 35.2% to $2.84 during Thursday's regular session. Trading volume for Yield10 Bioscience's stock is 9.5 million as of 12:30 EST. This is 29467.3% of its average full-day volume over the last 100 days. The company's market cap stands at $14.0 million.
  • Alpha Tau Medical (NASDAQ:DRTS) stock increased by 27.06% to $4.93. As of 12:30 EST, this security is trading at a volume of 436.6K shares, making up 862.8% of its average full-day volume over the last 100 days. The company's market cap stands at $340.2 million.
  • Omega Therapeutics (NASDAQ:OMGA) stock increased by 26.64% to $11.55. Trading volume for Omega Therapeutics's stock is 102.9K as of 12:30 EST. This is 276.0% of its average full-day volume over the last 100 days. The company's market cap stands at $554.9 million.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) stock increased by 24.39% to $2.74. Salarius Pharmaceuticals's stock is trading at a volume of 155.1K shares as of 12:30 EST. This is 234.8% of its average full-day volume over the last 100 days. The company's market cap stands at $6.2 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares rose 21.07% to $0.92. Trading volume for this security as of 12:30 EST is 2.9 million, which is 252.5% of its average full-day volume over the last 100 days. The company's market cap stands at $5.9 million.
  • EyePoint Pharmaceuticals (NASDAQ:EYPT) stock rose 19.99% to $4.56. As of 12:30 EST, EyePoint Pharmaceuticals's stock is trading at a volume of 1.2 million, which is 788.9% of its average full-day volume over the last 100 days. The company's market cap stands at $155.4 million.

Losers

  • Oramed Pharmaceuticals (NASDAQ:ORMP) shares declined by 76.6% to $2.53 during Thursday's regular session. Oramed Pharmaceuticals's stock is trading at a volume of 21.8 million shares as of 12:30 EST. This is 5303.5% of its average full-day volume over the last 100 days. The company's market cap stands at $98.9 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) shares declined by 21.49% to $0.95. As of 12:30 EST, Universe Pharmaceuticals's stock is trading at a volume of 829.8K, which is 423.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.6 million.
  • Vyant Bio (NASDAQ:VYNT) shares fell 16.17% to $0.86. The current volume of 245.4K shares is 65.4% of Vyant Bio's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $5.0 million.
  • Jaguar Health (NASDAQ:JAGX) stock declined by 15.5% to $0.1. Trading volume for Jaguar Health's stock is 32.3 million as of 12:30 EST. This is 565.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.7 million.
  • Novo Integrated Sciences (NASDAQ:NVOS) stock fell 14.49% to $0.13. Trading volume for this security as of 12:30 EST is 10.0 million, which is 478.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.5 million.
  • First Wave BioPharma (NASDAQ:FWBI) stock decreased by 14.05% to $0.71. As of 12:30 EST, this security is trading at a volume of 552.1K shares, making up 56.2% of its average full-day volume over the last 100 days. The company's market cap stands at $4.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.